Amrize (NYSE:AMRZ) CTO Purchases $207,080.00 in Stock

Amrize Ltd (NYSE:AMRZ) CTO Roald Brouwer bought 4,000 shares of the business’s stock in a transaction dated Friday, October 31st. The stock was acquired at an average cost of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the acquisition, the chief technology officer directly owned 9,000 shares in the company, valued at approximately $465,930. This trade represents a 80.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Roald Brouwer also recently made the following trade(s):

• On Wednesday, August 27th, Roald Brouwer bought 2,000 shares of Amrize stock. The stock was acquired at an average cost of $51.88 per share, for a total transaction of $103,760.00.

Amrize Stock Performance

AMRZ traded down $0.38 during trading on Tuesday, hitting $50.74. The stock had a trading volume of 1,990,784 shares, compared to its average volume of 3,670,772. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $28.06 billion and a price-to-earnings ratio of 65.05. The business has a 50-day moving average of $50.61. Amrize Ltd has a twelve month low of $44.12 and a twelve month high of $56.29.

Amrize (NYSE:AMRZ) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.78 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.03 by ($0.25). The business had revenue of $3.22 billion for the quarter.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on AMRZ shares. Wells Fargo & Company boosted their price objective on shares of Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Morgan Stanley set a $61.00 price objective on shares of Amrize and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. Citigroup boosted their price objective on shares of Amrize from $60.00 to $63.00 and gave the stock a “buy” rating in a research report on Monday. Oppenheimer initiated coverage on shares of Amrize in a report on Tuesday, September 9th. They issued an “outperform” rating and a $62.00 target price on the stock. Finally, Zacks Research raised shares of Amrize from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Amrize presently has a consensus rating of “Moderate Buy” and an average price target of $58.71.

Institutional Investors Weigh In On Amrize

Large investors have recently added to or reduced their stakes in the stock. State of Wyoming acquired a new stake in Amrize in the third quarter worth $32,000. Global Retirement Partners LLC acquired a new position in shares of Amrize during the third quarter valued at $48,000. Jones Financial Companies Lllp acquired a new position in shares of Amrize during the third quarter valued at $53,000. BNP Paribas Financial Markets acquired a new position in shares of Amrize during the second quarter valued at $59,000. Finally, Groupe la Francaise acquired a new position in shares of Amrize during the second quarter valued at $60,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.